Partial tumor radiation plus immunotherapy for advanced lung cancer
Part of Cancer clinical trials.
This trial tests combining partial tumor radiation with immunotherapy for people with advanced lung adenocarcinoma who cannot have surgery or standard radiation. It may help those whose cancer has stopped responding to previous treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of lung cancer called adenocarcinoma that cannot be removed with surgery.
- You cannot have standard radiation to the whole tumor or your cancer has not responded to previous treatments including immunotherapy.
- You are 18 years or older.
- If you could become pregnant, you agree to use effective birth control and have a negative pregnancy test.
- Your blood tests show enough white blood cells and neutrophils.
- Your tumor has at least 1% PD-L1, a protein that may help immunotherapy work better.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests combining a type of radiation therapy called SBRT with an immunotherapy drug called puterizumab for patients whose non-small cell lung cancer has spread to the lungs after prior immunotherapy. The goal is to see if this combination can help control the cancer.
This study looks at combining radiation therapy with immunotherapy for advanced breast cancer that has spread or cannot be surgically removed. The goal is to see if adding radiation after treatment helps improve outcomes.
This trial tests a new combination of chemotherapy, radiation, and immunotherapy (durvalumab) for people with stage III non-small cell lung cancer that cannot be removed with surgery. The goal is to see if giving a smaller, more focused radiation dose can be just as effective with fewer side effects.
This trial studies whether a more intensive form of targeted radiation, combined with immunotherapy (immune checkpoint inhibitors), can work better and be safe for people with advanced non-small cell lung cancer. You may be considered if your tumor is limited in size and you’re able to receive both treatments.
This study tests whether adding focused radiation therapy to immunotherapy can help patients with advanced non-small cell lung cancer whose cancer has progressed despite prior immunotherapy. The goal is to see if this combination works better than immunotherapy alone.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
Hear when a new Lung Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.